To hear about similar clinical trials, please enter your email below
 Trial Title: 
 POZIKIDS: Exercise and Comprehensive Care to Improve the Quality of Life of Children and Adolescents With Cancer 
 NCT ID: 
 NCT06321016 
 Condition: 
 Exercise 
 Childhood Cancer 
 Study type: 
 Interventional 
 Study phase: 
 N/A 
 Overall status: 
 Not yet recruiting 
 Study design: 
 Allocation: 
 N/A 
 Intervention model: 
 Single Group Assignment 
 Primary purpose: 
 Health Services Research 
 Masking: 
 None (Open Label) 
 Intervention: 
 Intervention type: 
 Other 
 Intervention name: 
 Physical exercise program 
 Description: 
 At least two sessions a week for a 6-month supervised and individualized physical
exercise program that will have two phases: one that will be carried out in person in the
hospital environment taking advantage of medical visits, and a second phase that will
allow the patient to carry out the exercise sessions from home with live virtual
supervision. 
 Intervention type: 
 Other 
 Intervention name: 
 Type of the physical exercise program 
 Description: 
 Two types of intervention are proposed depending on the age of the patients: Exercise
intervention for adolescents (12 to 18 years): training will be based on strength
training (2 - 3 sets of 8 - 12 repetitions) with elastic bands, weights, weights,
medicine balls or body weight and aerobic work on a stationary bike, treadmill or other
aerobic exercises. Sessions will last about 30-60 minutes (depending on the patient's
situation). Exercise intervention for children (4 to 11 years old): The aim will be to
work on basic motor skills through play, thus trying to avoid the delay in motor
development, and to indirectly work on their physical condition to better cope with the
effects of the treatments. Music, games that require movement and materials such as
balls, hoops, etc., will be used to motivate the child to move while enjoying themselves.
This will be done in sessions of 20 - 40 minutes. 
 Summary: 
 Objective: To assess the feasibility of a supervised, controlled and personalised
physical exercise programme and its potential efficacy in improving functional capacity
and quality of life in children and adolescents with cancer.
Design: Hybrid quasi-experimental pilot trial, clinical and phase I implementation.
Methods: The learning collaborative approach based on the Institute for Healthcare
Improvement Breakthrough Series Collaborative Model will be followed through quarterly
Plan-Do-Study-Act (P-D-S-A) cycles. Participants: For feasibility, at least, 45 patients
will be included in 3 successive PDSA cycles of at least 15 patients each, aged 4-18
years diagnosed with any type of cancer. Variables: clinical and socio-demographic, body
composition, physical condition and mobility, quality of life, physical activity and
implementation. Intervention: Everyone will receive a physical exercise intervention
combining strength and aerobic capacity work. Initially it will be carried out in the
hospital setting, and later in streaming supervised by a professional. The intervention
will be modelled through a formative evaluation process with the collaboration of all the
agents involved, experimenting in each cycle with an increasingly adapted version of the
exercise programme.
Statistical analysis: Recruitment rates will be calculated, characteristics associated
with project participation and adherence to the exercise programme will be identified.
Outcome variables will be compared before and after the intervention, identifying those
with the greatest validity, reliability and sensitivity to change, which will then be
used in phase II and III trials. 
 Criteria for eligibility: 
 Criteria: 
  
 Inclusion Criteria:
  -  Patients diagnosed with cancer and other neoplasms
  -  Age between 4 and 18 years at the time of inclusion in the study
  -  Patients diagnosed with cancer and other malignancies aged between 4 and 18 years
     who are experiencing relapse
  -  Paediatric patients requiring chemotherapy, radiotherapy, or oncological surgery
  -  Patients and parents or guardians who agree to participate in the study and sign the
     informed consent forms by current legislation depending on the patient's age.
Exclusion Criteria:
  -  Patients with cognitive deficits that prevent participation in and performance of
     physical exercise interventions.
  -  Patients with severe neurological pathology with a motor impairment that prevents or
     significantly hinders the performance of physical exercise
  -  Patients and families or guardians with language comprehension difficulties that
     make it difficult or impossible to carry out the physical exercise intervention.
  -  Patients < 16 years with a functional status score according to Lanskyi scale <60%
  -  Patients > 16 years with Karnofsky scale <60%.
  -  Any other criteria that the physician deems inappropriate for participation in the
     study 
  
 Gender: 
 All 
 Minimum age: 
 4 Years 
 Maximum age: 
 18 Years 
 Healthy volunteers: 
 No 
 Start date: 
 November 15, 2024 
 Completion date: 
 December 30, 2026 
 Lead sponsor: 
  
 Agency: 
 Nere Mendizabal 
 Agency class: 
 Other 
 Source: 
 Basque Health Service 
 Record processing date: 
 ClinicalTrials.gov processed this data on November 12, 2024 
 Source: ClinicalTrials.gov page: 
 https://clinicaltrials.gov/ct2/show/NCT06321016